HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.

Product support
with OnePath®

Takeda’s OnePath program offers product support for your patients prescribed HYQVIA.

OnePath Patient Enrollment for HYQVIA

OnePath product support
for your patients.

Through OnePath, eligible patients are connected with a Patient Support Manager who can assist them by:

OnePath can investigate insurance benefit issues

Facilitating an insurance benefits investigation

OnePath can work with specialty pharmacies

Working with specialty pharmacies to coordinate treatment access

Eligible Patients can enroll in the OnePath co-pay assistance program

Enrolling eligible* patients in the OnePath co-pay assistance program or providing information about other financial assistance options

OnePath can assist with in home administration training from a trained nurse

Getting patients and caregivers started with in-home self-administration training, led by a specially trained nurse (if applicable)

OnePath informs patients with educational resources

Informing patients and caregivers about educational resources available to them

OnePath Co-Pay Assistance Program

The OnePath Co-Pay Assistance Program helps eligible patients cover certain out-of-pocket treatment costs.

To enroll a patient in OnePath, complete a HYQVIA Start Form with your patient and fax it to1-833-388-5467.

OnePath Customer Service Rep

Once you've prescribed HYQVIA

For practices prescribing HYQVIA, we've developed training especially for nurses and conducted by our OnePath Clinical Educators on site or remotely.

This free resource is designed to provide the information and instruction necessary to administer HYQVIA.

This program is intended for healthcare providers who treat adult PI patients with HYQVIA, or who train other healthcare professionals in their facility who treat these patients.

The OnePath Clinical Educators program is not intended for patients.